Current Edition

Upcoming Events

Advertisement

news

How a long shot ALS drug came before the FDA

The drug's beginnings, according to the two former students there to see them, were quite humble. About a decade ago, Justin Klee and Josh Cohen were undergraduates ...
Continue Reading →
news

Intercept, awaiting needed trial data, pulls its NASH drug application in Europe

Intercept's decision to withdraw an application for obeticholic acid in Europe doesn't necessarily come as a surprise. Top executives hinted such an outcome was possi...
Continue Reading →